Phase I/II – Other

643 trials 280 recruiting

Filter these 643 trials by condition, country, sponsor and more.

Open in Search →

A clinical study of patritumab deruxtecan (HER3-DXd) in children with cancer (MK-9999-01C) Recruiting

2024-518771-66-00 Hepatoblastoma, Rhabdomyosarcoma 2025-07-01
Phase I Study of PM534 to Patients with Advanced Solid Tumors Recruiting

2024-519013-57-00 Advances solid tumors 2025-06-23
A study to assess safety, cellular kinetics and exploratory efficacy of rapcabtagene autoleucel in rheumatoid arthritis and Sjogren’s diseas… Recruiting

2024-514596-18-00 Difficult to treat rheumatoid arthritis 2025-06-20
A Phase 1/2a Study of BMS-986507 (BL-B01D1) in Adult Participants with Advanced Solid Tumors Recruiting

2024-514947-27-00 Advance solid tumors 2025-06-18
A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours Recruiting

2023-504246-64-02 Relapsed/refractory neuroblastoma and other solid tumou 2025-06-04
Assessment of the safety and efficacy of a hepatitis B vaccine in adult patients with hepatitis B Recruiting

2023-507623-36-00 Chronic hepatitis B 2025-05-26
A clinical study of MK-3120 in people with solid tumors (MK-3120-002) Recruiting

2024-516817-19-00 Advanced/metastatic solid tumor disease 2025-05-23
A Phase I/II study of GSK5733584 in combination with anti-cancer therapies for advanced solid tumors Recruiting

2024-517147-31-00 Tumours, Gynecological 2025-05-23
A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants with Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping t… Recruiting

2024-517584-23-00 Duchenne Muscular Dystrophy 2025-05-16
A Phase 1b Open-Label Study to Evaluate the Safety and Tolerability of Eganelisib as Monotherapy and in Combination with Cytarabine in Patie… Recruiting

2024-518071-58-00 Relapsed/refractory (r/r) acute myeloid leukemia (AML) 2025-05-16
A first time in man study to look at the safety of the experimental drug CCS1477 and what effects it has on cancers that affect the blood, b… Recruiting

2024-519498-20-00 Acute Myeloid Leukaemia (AML)/higher-risk Myelodysplast 2025-05-13
Lu177-Dotatate every 16 weeks to reduce adverse events in patients with midgut neuroendocrine tumors Recruiting

2024-517921-14-00 Neuroendocrine tumors of midgut origin 2025-05-07
T-Guard in dcSSc Recruiting

2024-517283-28-00 diffuse cutaneous systemic sclerosis 2025-04-29
Study of Intravenous Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor to Assess Adverse Events and Change in … Recruiting

2024-514465-18-00 Advanced or Metastatic Non-Squamous NSCLC 2025-04-23
Phase I/II study to evaluate the efficacy and safety of bacterial collagenase administered in patients with Peyronie's Disease Recruiting

2023-509621-45-00 Peyronie’s Disease 2025-04-22
Addition of sulfalasazine to chemotherapy for the treatment of AML in the elderly Recruiting

2024-513084-38-00 Recently diagnosed non favorable Acute Myeloid Leukemia 2025-04-15
A Phase 1b/2 study of arfolitixorin as part of 5-fluorouracil-based treatment regimens in the first-line treatment of metastatic colorectal … Recruiting

2024-516802-43-00 metastatic colorectal cancer 2025-04-09
Exploiting the synergistic effect of PARP inhibition with cisplatin and hyperthermia during interval cytoreductive surgery and HIPEC in ovar… Recruiting

2024-519170-39-00 fallopian tube cancer 2025-04-07
A safety and efficacy study of RTX001 autologous macrophage therapy in participants with decompensated liver cirrhosis Recruiting

2024-516288-10-00 Liver Cirrhosis 2025-03-21
A Phase I/II with Ruxolitinib in Patients with Myelofibrosis (MF) who are Unresponsive to JAK inhibitors (HEMA-MED) Recruiting

2024-515252-20-00 Myelofibrosis (MF) unresponsive to JAK inhibitors 2025-03-14
A clinical study of MK-6070 and ifinatamab deruxtecan in people with small cell lung cancer (MK-6070-002) Recruiting

2024-517926-25-00 Small cell lung cancer 2025-03-12
Reduction of plasma cells as an approach to reset autoimmunity in rheumatoid arthritis Recruiting

2024-511536-27-00 Rheumatoid arthritis 2025-03-11
A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting

2024-515034-33-00 Chronic Lymphocytic Leukaemia 2025-03-05
CD8 PET imaging in metastatic solid tumours; A phase II, open label, multi-center study of 89Zr-DF-crefmirlimab for CD8 positron emission to… Recruiting

2024-515885-15-00 Patients with metastatic solid tumours, where clinical 2025-03-04